Cargando…
Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083535/ https://www.ncbi.nlm.nih.gov/pubmed/35548365 http://dx.doi.org/10.3389/fphar.2022.854593 |
| _version_ | 1784703438009925632 |
|---|---|
| author | Liu, Zengying Zhang, Ningxin Zhou, Bin Xu, Yan |
| author_facet | Liu, Zengying Zhang, Ningxin Zhou, Bin Xu, Yan |
| author_sort | Liu, Zengying |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9083535 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90835352022-05-10 Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy Liu, Zengying Zhang, Ningxin Zhou, Bin Xu, Yan Front Pharmacol Pharmacology Frontiers Media S.A. 2022-04-25 /pmc/articles/PMC9083535/ /pubmed/35548365 http://dx.doi.org/10.3389/fphar.2022.854593 Text en Copyright © 2022 Liu, Zhang, Zhou and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Liu, Zengying Zhang, Ningxin Zhou, Bin Xu, Yan Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy |
| title | Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy |
| title_full | Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy |
| title_fullStr | Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy |
| title_full_unstemmed | Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy |
| title_short | Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy |
| title_sort | commentary: dapagliflozin mediates plin5/pparα signaling axis to attenuate cardiac hypertrophy |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083535/ https://www.ncbi.nlm.nih.gov/pubmed/35548365 http://dx.doi.org/10.3389/fphar.2022.854593 |
| work_keys_str_mv | AT liuzengying commentarydapagliflozinmediatesplin5pparasignalingaxistoattenuatecardiachypertrophy AT zhangningxin commentarydapagliflozinmediatesplin5pparasignalingaxistoattenuatecardiachypertrophy AT zhoubin commentarydapagliflozinmediatesplin5pparasignalingaxistoattenuatecardiachypertrophy AT xuyan commentarydapagliflozinmediatesplin5pparasignalingaxistoattenuatecardiachypertrophy |